Acharya chemicals & Herbert Brown Pharmaceutical & Research Laboratories
- Acharya Chemicals & Herbert Brown Pharmaceutical & Research Laboratories have more than 16+ years experience in GMP environment.
- Class 100,000 clean rooms.
- APIs available in micronized, jet/pin milled form
- Solid reagents/intermediates available in tablet/pellet form
- 2-8℃ Finished goods storage and transportation
- Separate warehouse for solid and liquid/solvent raw materials
- APIs being manufactured are Novel polymorphs, extremely moisture sensitive, temperature sensitive
- All APIs and Intermediates are in Solid form
- Final API filtration in closed conditions for certain APIs
- Upto 7 step synthesis manufacturing process being followed for certain APIs
- APIs and Intermediates being sold in US and European countries
- Acharya Chemicals received USFDA EIR in May 2024
- Acharya Chemicals received EUGMP certificate in May 2023
Keeping a close eye on quality
We take pride in being a well-known group company in API, intermediates and nucleosides manufacturing, dedicated to producing high-quality pharmaceutical ingredients for global healthcare solutions. With decades of experience and an unwavering commitment to excellence, we have become a preferred manufacturing partner for pharmaceutical companies worldwide. Our certifications and approvals from EDQM, USFDA, PMDA are a testament to our commitment to delivering safe, reliable, and high-quality APIs.
Products
API
- Metronidazole Benzoate EP / BP (COS Available)
- Methyl Nicotinate EP (ASMF Available)
- Benzyl Nicotinate DAB (ASMF Available)
- Chlordiazepoxide (offered only Locally)
- Valbenazine Tosylate (Novel Polymorph)
API Under Development
- Bempedoic Acid
- Silodosin HCl
- Bisoprolol Fumarate
- Sitagliptin Phosphate monohydrate
- Apixaban
- Linagliptin
- Bosentan Monohydrate
- Donepezil HCl
- Desloratadine
- Cinacalcet HCl
Intermediates
- Phenyl-N-Tert-Butylnitrone
- Caronic Anhydride
- Myosmine
- 1, 2, 5-Trimethylpiperidine-4-One
- 2-Aminobenzonitile
- 2-Amino-5-chlorobenzophenone
- 5-Acetyl-3-chloroiminodibenzyl
- 3-Chloroiminodibenzyl
- 4-(Phthalimido) Cyclohexanone.
- S-(-)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole
- 5-(4-Methyl-1H-imidazol-1-yl)-3-nitrobenzotrifluoride.
- 4-Chloro-1-(4-fluorophenyl)butan-1-one
- 4-(4-Chlorophenyl)piperidin-4-ol
- 4-(1,1-dimethylethyl)-N-[6-chloro-5-(2-methoxyphenoxy)[2,2′-bipyrimidin]-4-yl]-benzenesulfonamide.
- 1-(3-Benzoyloxypropyl)-7-cyano-5-(2-nitropropyl) indoline.
Pharma Partner for API and Advanced Intermediates
Commercial Production
- In house Technology
- In license Technology
Discovery – Preclinical P1/2/3
- Process Development
Full Regulatory Support
- CMC